2022-05-19

MLO Online: COVID-19’s impact on testing practices for STIs

James Walker

The decrease in STI testing seen during the first few months of the pandemic resulted in low reporting of disease. As patients get back to doctors’ offices to catch-up on delayed screenings, STI testing demand is now on the rise. Laboratories are faced with higher volumes of tests to process with fewer staff members and shortages of laboratory consumables.

James Walker, Global Business Leader of Molecular Diagnostics & Women’s Health and Cancer at BD, shares his insights into the challenges faced by labs and the steps labs can take to diagnose patients with greater accuracy and efficiency.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

Smiling woman smiling while painting
STIs | Vaginitis | Brochures
Vaginitis and STIs: The right treatment begins with the right diagnosis
smiling woman
Cervical Cancer | News & Updates
Press Release: Women in U.S. can now collect their own sample for cervical cancer screening
Chris Beddard, Vice President, U.S. Marketing, Integrated Diagnostic Solutions at BD
Cervical Cancer | News & Updates
NJBIZ Conversations: Chris Beddard